Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Uguccioni

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|May 8, 2021
Effectiveness of fondaparinux vs unfractionated heparin following percutaneous coronary intervention in survivors of out-of-hospital cardiac arrest due to acute myocardial infarctionLeonardo De Luca, Massimo Uguccioni, Enrico Natale, et al.
Cardiorenal Medicine|May 1, 2020
Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance NetworkCarlo Lavalle, Luca Di Lullo, Antonio Bellasi, et al.
Heart, Lung & Circulation|May 17, 2021
Fondaparinux During Intra-Aortic Balloon Pump Counterpulsation in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary InterventionLeonardo De Luca, Massimo Uguccioni, Rita Lucia Putini, et al.
Clinical Drug Investigation|March 21, 2020
Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series AnalysisDomenico Acanfora, Pietro Scicchitano, Chiara Acanfora, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 24, 2004
[Cardiovascular epidemiology: trends of risk factors in Italy]Diego Vanuzzo, Lorenza Pilotto, Massimo Uguccioni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 31, 2016
Evaluation of the appropriateness of the preclinical phase (stage A and stage B) of heart failure Management in Outpatient clinics in Italy rationale and design of the 'VASTISSIMO' studyGian F Mureddu, Stefano Nistri, Pompilio Faggiano, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 14, 2014
[Cardiovascular risk profile and lifestyle habits in a cohort of Italian cardiologists. Results of the SOCRATES survey]Pompilio Faggianoi, Pier Luigi Temporelli, Giovanni Zito, et al.
JACC. Heart Failure|March 14, 2016
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure: Insights From the IMAGE-HF StudyGiovanni Pulignano, Donatella Del Sindaco, Andrea Di Lenarda, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 20, 2020
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registryLeonardo De Luca, Dario Formigli, Jennifer Meessen, et al.
International Journal of Cardiology|January 10, 2021
Impact of history of depression on 1-year outcomes in patients with chronic coronary syndromes: An analysis of a contemporary, prospective, nationwide registryLeonardo De Luca, Pier Luigi Temporelli, Antonio Francesco Amico, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|May 8, 2021
Effectiveness of fondaparinux vs unfractionated heparin following percutaneous coronary intervention in survivors of out-of-hospital cardiac arrest due to acute myocardial infarctionLeonardo De Luca, Massimo Uguccioni, Enrico Natale, et al.
Cardiorenal Medicine|May 1, 2020
Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance NetworkCarlo Lavalle, Luca Di Lullo, Antonio Bellasi, et al.
Heart, Lung & Circulation|May 17, 2021
Fondaparinux During Intra-Aortic Balloon Pump Counterpulsation in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary InterventionLeonardo De Luca, Massimo Uguccioni, Rita Lucia Putini, et al.
Clinical Drug Investigation|March 21, 2020
Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series AnalysisDomenico Acanfora, Pietro Scicchitano, Chiara Acanfora, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 24, 2004
[Cardiovascular epidemiology: trends of risk factors in Italy]Diego Vanuzzo, Lorenza Pilotto, Massimo Uguccioni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 31, 2016
Evaluation of the appropriateness of the preclinical phase (stage A and stage B) of heart failure Management in Outpatient clinics in Italy rationale and design of the 'VASTISSIMO' studyGian F Mureddu, Stefano Nistri, Pompilio Faggiano, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|May 14, 2014
[Cardiovascular risk profile and lifestyle habits in a cohort of Italian cardiologists. Results of the SOCRATES survey]Pompilio Faggianoi, Pier Luigi Temporelli, Giovanni Zito, et al.
JACC. Heart Failure|March 14, 2016
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure: Insights From the IMAGE-HF StudyGiovanni Pulignano, Donatella Del Sindaco, Andrea Di Lenarda, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 20, 2020
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registryLeonardo De Luca, Dario Formigli, Jennifer Meessen, et al.
International Journal of Cardiology|January 10, 2021
Impact of history of depression on 1-year outcomes in patients with chronic coronary syndromes: An analysis of a contemporary, prospective, nationwide registryLeonardo De Luca, Pier Luigi Temporelli, Antonio Francesco Amico, et al.
Pageof 6